At least 869 people await decisions from the Countermeasures Injury Compensation Program, set up to compensate people who have been injured by COVID vaccines and drugs. Experts say the “secret,” “opaque” and “stingy” program is slow-walking applicants.
Currently, 869 people are awaiting decisions from the Countermeasures Injury Compensation Program (CICP), which was set up to compensate people who have been injured by fast-tracked and experimental “countermeasures,” including vaccines and other drugs.
Because pharmaceutical companies have immunity from lawsuits, CICP exists to offer payouts for lost wages and medical expenses from vaccine injuries. But the program has paid meager handouts to a handful of applicants among hundreds in the past 10 years and has not adjudicated even one COVID vaccine decision to date.
“It’s a lousy program,” said Peter Meyers, professor of law emeritus at the George Washington University Law School and former director of the school’s Vaccine Injury Litigation Clinic. “It’s a secretive, opaque program whereby some unknown officials within the Department of Health and Human Services will make decisions; we don’t know how many people are adjudicating, who they are or what the process is.”
Applicants have only a year from the date of vaccination to apply for CICP benefits and may wait “months and months” for a decision, which is not published, Meyers added. So the public does not know who is granted or refused benefits or why. CICP decisions cannot be appealed.